In contrast, the high-risk group showed enrichment of pathways associated with IL-17 signaling, inflammatory bowel disease, intestinal immune network for IgA production, and viral protein interaction with cytokine and cytokine receptors (Figures 4A, B; Supplementary Figure S6). This evidence concerns the gene IL17A and inflammatory bowel disease.